Eagle Pharmaceuticals
EGRX
$1.82
Share price
15.00%
Change (1 day)
-76.58%
Change (1 year)
Categories
Operating Margin for Eagle Pharmaceuticals (EGRX)
Operating Margin as of March 2025 (TTM): 13.84%
According to Eagle Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 13.84%. At the end of 2022 the company had an Operating Margin of 19.40%.
Operating Margin history for Eagle Pharmaceuticals from 2013 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 19.40% | -831.88% |
| 2021 | -2.65% | -121.96% |
| 2020 | 12.07% | 7.53% |
| 2019 | 11.23% | -29.63% |
| 2018 | 15.96% | -48.22% |
| 2017 | 30.82% | 9.29% |
| 2016 | 28.20% | 625.47% |
| 2015 | 3.89% | -103.85% |
| 2014 | -100.91% | 98.69% |
| 2013 | -50.79% | -93.61% |
| 2012 | -794.17% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | 18.78% | 35.69% | 🇺🇸 USA |
 | 10.93% | -21.03% | 🇬🇧 UK |
 | 26.37% | 90.53% | 🇨🇭 Switzerland |
 | -7.76% | -156.07% | 🇮🇱 Israel |
 | 13.78% | -0.43% | 🇺🇸 USA |
 | 28.15% | 103.40% | 🇺🇸 USA |
 | -17.34% | -225.29% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.